Characteristics of innate, humoral and cellular immunity in children with non-severe SARS-CoV-2 infection
- PMID: 38101522
- DOI: 10.1016/j.jinf.2023.12.003
Characteristics of innate, humoral and cellular immunity in children with non-severe SARS-CoV-2 infection
Abstract
The symptoms of children infected with SARS-CoV-2 are mainly asymptomatic, mild, moderate, and a few severe cases. To understand the immune response characteristics of children infected with SARS-COV-2 who do not develop severe cases, 82 children infected with the SARS-CoV-2 delta strain were recruited in this study. Our results showed that high levels of IgG, IgM, and neutralization antibodies appeared in children infected with SARS-CoV-2. SARS-CoV-2 induced upregulation of both pro-inflammatory factors including TNF-α and anti-inflammatory factors including IL-4 and IL-13 in the children, even IL-10. The expression of INF-α in infected children also showed a significant increase compared to healthy children. However, IL-6, one of the important inflammatory factors, did not show an increase in infected children. It is worth noting that a large number of chemokines reduced in the SARS-CoV-2-infected children. Subsequently, TCR Repertoire, TCRβ bias, and preferential usage were analyzed on data of TCR next-generation sequencing from 8 SARS-CoV-2-infected children and 8 healthy controls. We found a significant decrease in TCR clonal diversity and a significant increase in TCR clonal expansion in SARS-CoV-2-infected children compared to healthy children. The most frequent V and J genes in SARS-CoV-2 children were TRBV28 and TRBJ2-1. The most frequently VβJ gene pairing in SARS-CoV-2 infected children was TRBV20-1-TRBJ2-1. The strong antiviral antibody levels, low expression of key pro-inflammatory factors, significant elevation of anti-inflammatory factors, and downregulation of many chemokines jointly determine that SARS-CoV-2-infected children rarely develop severe cases. Overall, our findings shed a light on the immune response of non-severe children infected with SARS-CoV-2.
Keywords: Antibody protection; Children; Cytokines and chemokines; SARS-CoV-2; TCR repertoire.
Copyright © 2023. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Diversity of immune responses in children highly exposed to SARS-CoV-2.Front Immunol. 2023 Mar 3;14:1105237. doi: 10.3389/fimmu.2023.1105237. eCollection 2023. Front Immunol. 2023. PMID: 36936972 Free PMC article.
-
Mild Cytokine Elevation, Moderate CD4+ T Cell Response and Abundant Antibody Production in Children with COVID-19.Virol Sin. 2020 Dec;35(6):734-743. doi: 10.1007/s12250-020-00265-8. Epub 2020 Jul 22. Virol Sin. 2020. PMID: 32699972 Free PMC article.
-
Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19.Front Immunol. 2022 Apr 5;13:821730. doi: 10.3389/fimmu.2022.821730. eCollection 2022. Front Immunol. 2022. PMID: 35479098 Free PMC article.
-
The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection.Front Immunol. 2022 Jun 27;13:904686. doi: 10.3389/fimmu.2022.904686. eCollection 2022. Front Immunol. 2022. PMID: 35833134 Free PMC article. Review.
-
Utility of Bulk T-Cell Receptor Repertoire Sequencing Analysis in Understanding Immune Responses to COVID-19.Diagnostics (Basel). 2022 May 13;12(5):1222. doi: 10.3390/diagnostics12051222. Diagnostics (Basel). 2022. PMID: 35626377 Free PMC article. Review.
Cited by
-
Efficient boosting of Omicron-reactive memory B cells after breakthrough infection protects from repeated exposure.iScience. 2025 Mar 25;28(4):112278. doi: 10.1016/j.isci.2025.112278. eCollection 2025 Apr 18. iScience. 2025. PMID: 40264792 Free PMC article.
-
Single-cell profiling of peripheral blood mononuclear cells from patients treated with oncolytic adenovirus TILT-123 reveals baseline immune status as a predictor of therapy outcomes.Cancer Gene Ther. 2025 Jun;32(6):649-661. doi: 10.1038/s41417-025-00901-z. Epub 2025 Apr 10. Cancer Gene Ther. 2025. PMID: 40211048 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous